Table 2.

Stakeholder Prioritization of Questions: Population to Study (n = 37)

Final Rank	Question	Mean Score	Percentage Who Ranked 1 or 2
1	How do LDCT screening results (positive or negative test results) affect motivation to quit, and what is the resultant impact on effectiveness of cessation?	3.43	37.8%
2	How do patients’ beliefs, attitudes, and perceived or real barriers to quitting impact the effectiveness of cessation interventions in the context of lung cancer screening?	3.49	32.4%
3	How does motivation to quit impact the effectiveness of cessation interventions in lung cancer screening? What approaches are most effective among smokers with low motivation to quit?	3.68	32.4%
4	Who benefits the most from evidence-based interventions for smoking cessation in lung cancer screening? Evidence-based cessation interventions include counseling, nicotine replacement, and other pharmacotherapy, alone or in combination.	4.11	32.4%
5	What are the characteristics of populations for whom evidence-based cessation interventions are not effective? Examples might include smokers with comorbid mental health, physical, or substance use disorders; individuals of low socioeconomic status; or members of racial or ethnic minority groups.	4.14	21.6%
6	For patients who undergo a shared decision-making visit about lung cancer screening and decide not to get screened, what is the effectiveness of smoking cessation interventions, and how does it vary from patients who do undergo lung cancer screening?	4.43	24.3%
7	For patients who recently quit smoking, how does lung cancer screening impact smoking relapse and patients’ motivation to stay quit?	4.73	18.9%

Definition of abbreviation: LDCT = low-dose computed tomography.